LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,013,000 | -10.0% | 43,919 | -0.8% | 0.31% | -10.9% |
| Q1 2019 | $5,568,000 | +1.1% | 44,289 | +9.1% | 0.35% | +3.0% |
| Q4 2018 | $5,508,000 | -1.6% | 40,590 | +99.0% | 0.34% | +29.0% |
| Q3 2018 | $5,599,000 | -23.2% | 20,397 | -42.0% | 0.26% | -23.6% |
| Q2 2018 | $7,290,000 | +39.5% | 35,188 | +11.2% | 0.34% | +33.5% |
| Q1 2018 | $5,227,000 | +6.3% | 31,650 | -11.9% | 0.26% | +18.4% |
| Q4 2017 | $4,918,000 | -20.0% | 35,916 | -20.4% | 0.22% | -13.9% |
| Q3 2017 | $6,145,000 | -24.5% | 45,134 | -32.7% | 0.25% | -26.7% |
| Q2 2017 | $8,137,000 | +50.6% | 67,026 | +31.3% | 0.34% | +53.6% |
| Q1 2017 | $5,404,000 | -34.3% | 51,059 | -37.4% | 0.22% | -38.3% |
| Q2 2015 | $8,228,000 | +5.5% | 81,547 | -19.4% | 0.36% | +7.4% |
| Q1 2015 | $7,802,000 | – | 101,186 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |